NDT Advance Access first published online on April 19, 2005
This version published online on May 3, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh828
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Renal Section, Medical Service, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA; Renal-Electrolyte Division, Department of Medicine, Pittsburgh, PA, USA
* To whom correspondence should be addressed.
Letter
Functional renal artery obstruction following percutaneous kidney biopsy
2 Radiology Service, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
3 Radiology Service, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA
Steven D. Weisbord, E-mail: steven.weisbord{at}med.va.gov
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. F. Wong Rituximab in refractory antineutrophil cytoplasmic antibody-associated vasculitis: what is the current evidence? Nephrol. Dial. Transplant., January 1, 2007; 22(1): 32 - 36. [Full Text] [PDF] |
||||
![]() |
R. Stasi, E. Stipa, G. Del Poeta, S. Amadori, A. C. Newland, and D. Provan Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab Rheumatology, November 1, 2006; 45(11): 1432 - 1436. [Abstract] [Full Text] [PDF] |
||||

